Showing results (341-350 of 3,159) with videos related to
Sort By:
Pageof 316
Swiss Medical Weekly|July 8, 2011
Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional surveyPhilipp Andreas Gerber, David Spirk, Michael Brändle, et al.Swiss Medical Weekly|July 8, 2011
Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patientsPirmin Schmid, Andrea Mordasini, Martin Luginbühl, et al.Swiss Medical Weekly|August 31, 2011
Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexesD PisetskySwiss Medical Weekly|October 13, 2011
Low molecular weight hyaluronan, via AP-1 and NF-κB signalling, induces IL-8 in transformed bronchial epithelial cellsChristiaan D Ochoa, Hari G Garg, Charles A Hales, et al.Swiss Medical Weekly|September 30, 2011
Giant cell arteritis--a changing entityF Kesten, M Aschwanden, P Gubser, et al.Swiss Medical Weekly|September 9, 2011
Prevention--a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD MeetingNicole Probst-Hensch, Marcel Tanner, Claudia Kessler, et al.Swiss Medical Weekly|March 13, 2012
Meta-analyses: what they can and cannot doAlain J Nordmann, Benjamin Kasenda, Matthias BrielSwiss Medical Weekly|March 13, 2012
Is a change in vocal loudness a first step towards becoming a medical doctor?Christiane Kiese-Himmel, Wolfgang Himmel, Maria Rodenstock, et al.Swiss Medical Weekly|September 2, 2011
Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET). A review of the BASKET trialsMatthias Pfisterer, Fabian Nietlispach, Raban Jeger, et al.Swiss Medical Weekly|February 28, 2012
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevirPageof 316